96102-85-1 Usage
Uses
Used in Pharmaceutical Industry:
4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid is used as an intermediate in the synthesis of pharmaceuticals for its unique molecular structure and potential applications in the development of new drugs.
Used in Agrochemical Industry:
4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid is used as an intermediate in the synthesis of agrochemicals, contributing to the development of innovative agricultural products.
Used in Organic Synthesis:
The carboxylic acid group of 4-Formyl-bicyclo[2.2.2]octane-1-carboxylic acid allows for easy functionalization and modification, making it a versatile component in various chemical processes and organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 96102-85-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,1,0 and 2 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 96102-85:
(7*9)+(6*6)+(5*1)+(4*0)+(3*2)+(2*8)+(1*5)=131
131 % 10 = 1
So 96102-85-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H14O3/c11-7-9-1-4-10(5-2-9,6-3-9)8(12)13/h7H,1-6H2,(H,12,13)
96102-85-1Relevant academic research and scientific papers
NOVEL SYNTHETIC METHODS
-
Page/Page column 38, (2011/06/19)
Described herein are xanthine-containing compounds and processes for their synthesis.
Synthesis of specifically deuterated adenosine A1 antagonist: BG9928
Conlon, Patrick R.,Kiesman, William F.
, p. 219 - 223 (2007/12/29)
BG9928, a high affinity adenosine A1 antagonist, is currently in Phase II clinical trials for the treatment of congestive heart failure. A deuterium-labeled version of the molecule was synthesized and used as a standard for in vivo pharmacokinetic and in vitro metabolism studies. The labeled form of 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2] oct-1-yl]-propionic acid (BG9928) was obtained in a convergent manner by joining two major building blocks: the specifically labeled heterocycle 5,6-diamino-1,3-dipropyl-1H-pyrimidine-2,4-dione (4) and the hemiester 4-(2-methoxycarbonyl-ethyl)-bicyclo[2.2.2]octane-1-carboxylic acid (10). Copyright
